March 29, 2019 / 9:53 PM / 22 days ago

U.S. moves to toss Gilead whistleblower lawsuit over HIV drugs

The U.S. Justice Department has moved to dismiss a closely watched whistleblower lawsuit accusing Gilead Sciences Inc of covertly arranging to have key ingredients for HIV medications made at a Chinese facility that had quality control issues.

Thursday’s motion in federal court in San Francisco came after the U.S. Supreme Court in January rejected Gilead’s request to review a 9th U.S. Circuit Court of Appeals ruling that revived the lawsuit two former Gilead employees filed under the False Claims Act.

To read the full story on WestlawNext Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below